Ann Thorac Surg 2008;86:27-28. doi:10.1016/j.athoracsur.2008.04.111
© 2008 The Society of Thoracic Surgeons
Original Articles: Adult Cardiac
Invited Commentary
Song Wan, MD, FRCS
Division of Cardiothoracic Surgery, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong, China
(Email: swan@cuhk.edu.hk).
| The first 20% of the full text of this article appears below. |
Although it is well recognized that hypoglycemic and hyperglycemic conditions during cardiopulmonary bypass (CPB) can lead to untoward clinical outcomes, normoglycemia in this particular setting may still need to be better defined. In the current randomized study involving 52 patients undergoing coronary artery bypass grafting (CABG), Albacker and colleagues [1] demonstrated that maintaining a high blood insulin level perioperatively while maintaining the lower limit of normoglycemia could result in a reduced production of pro-inflammatory cytokines after CPB. Echoing with their previous observation [2], such treatment is associated with better myocardial protection as reflected by the . . . [Full Text of this Article]
Related Article
-
High-Dose Insulin Therapy Attenuates Systemic Inflammatory Response in Coronary Artery Bypass Grafting Patients
- Turki Albacker, George Carvalho, Thomas Schricker, and Kevin Lachapelle
Ann. Thorac. Surg. 2008 86: 20-27.
[Abstract]
[Full Text]
[PDF]
Copyright © 2008 by The Society of Thoracic Surgeons.